ITGAM and neoplasm: We also used their gating for inflammatory monocytes CD45+CD11b+F480+Ly6C+), where we saw a significant decrease in both the tumour (0.4 FC, p < 0.0001) and spleen (0.6 FC, p = 0.0008, Figure S5B,D).